$NHI
National Health Investors Inc

2020 Q1 Form 10-Q Financial Statement

#000087786020000069 Filed on May 11, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q4 2019 Q1
Revenue $83.08M $82.20M $76.11M
YoY Change 9.16% 11.08% 4.62%
Cost Of Revenue $1.550M $1.590M $1.090M
YoY Change 42.2%
Gross Profit $81.55M $80.60M $75.02M
YoY Change 8.7%
Gross Profit Margin 98.16% 98.06% 98.57%
Selling, General & Admin $4.890M $3.820M $4.830M
YoY Change 1.24% 39.93% 4.32%
% of Gross Profit 6.0% 4.74% 6.44%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $20.44M $19.60M $18.49M
YoY Change 10.56% 8.89% 6.67%
% of Gross Profit 25.07% 24.32% 24.65%
Operating Expenses $42.58M $23.51M $40.43M
YoY Change 5.32% 13.08% 20.41%
Operating Profit $38.97M $57.09M $35.68M
YoY Change 9.23% -8.91%
Interest Expense $14.14M -$14.30M $13.52M
YoY Change 4.6% 11.28% 16.39%
% of Operating Profit 36.28% -25.05% 37.89%
Other Income/Expense, Net
YoY Change
Pretax Income $61.06M $42.04M $35.68M
YoY Change 71.13% 13.38% -7.16%
Income Tax
% Of Pretax Income
Net Earnings $61.02M $42.04M $35.68M
YoY Change 71.03% 13.37% -7.16%
Net Earnings / Revenue 73.45% 51.15% 46.88%
Basic Earnings Per Share $1.37 $0.95 $0.83
Diluted Earnings Per Share $1.37 $0.95 $0.83
COMMON SHARES
Basic Shares Outstanding 44.61M shares 44.11M shares 42.83M shares
Diluted Shares Outstanding 44.62M shares 44.33M shares 43.13M shares

Balance Sheet

Concept 2020 Q1 2019 Q4 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $46.00M $5.200M $5.200M
YoY Change 784.62% 10.64% 62.5%
Cash & Equivalents $46.05M $5.215M $5.177M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $3.600M $3.212M $2.900M
Other Receivables $85.70M $86.10M $75.10M
Total Short-Term Assets $135.3M $94.50M $83.20M
YoY Change 62.62% -19.02% -27.15%
LONG-TERM ASSETS
Property, Plant & Equipment $2.693B $2.560B $2.435B
YoY Change 10.62% 8.18% 6.5%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $433.0K $0.00
YoY Change
Other Assets $33.80M $28.90M $14.10M
YoY Change 139.72% 445.28% 71.95%
Total Long-Term Assets $3.033B $2.948B $2.723B
YoY Change 11.36% 11.92% 11.36%
TOTAL ASSETS
Total Short-Term Assets $135.3M $94.50M $83.20M
Total Long-Term Assets $3.033B $2.948B $2.723B
Total Assets $3.168B $3.042B $2.806B
YoY Change 12.88% 10.6% 9.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $34.70M $26.30M $21.40M
YoY Change 62.15% 32.16% 29.7%
Accrued Expenses $1.200M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $94.60M $83.80M $78.60M
YoY Change 20.36% 14.48% -0.88%
LONG-TERM LIABILITIES
Long-Term Debt $1.549B $1.441B $1.287B
YoY Change 20.33% 12.39% 10.95%
Other Long-Term Liabilities $17.40M $19.80M $24.60M
YoY Change -29.27% 230.0%
Total Long-Term Liabilities $1.566B $1.460B $1.312B
YoY Change 19.4% 13.4% 13.07%
TOTAL LIABILITIES
Total Short-Term Liabilities $94.60M $83.80M $78.60M
Total Long-Term Liabilities $1.566B $1.460B $1.312B
Total Liabilities $1.661B $1.544B $1.390B
YoY Change 19.46% 13.46% 12.16%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $1.505B $1.506B $1.407B
YoY Change 6.98% 9.93% 9.15%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.496B $1.498B $1.416B
YoY Change
Total Liabilities & Shareholders Equity $3.168B $3.042B $2.806B
YoY Change 12.88% 10.6% 9.64%

Cashflow Statement

Concept 2020 Q1 2019 Q4 2019 Q1
OPERATING ACTIVITIES
Net Income $61.02M $42.04M $35.68M
YoY Change 71.03% 13.37% -7.16%
Depreciation, Depletion And Amortization $20.44M $19.60M $18.49M
YoY Change 10.56% 8.89% 6.67%
Cash From Operating Activities $57.08M $56.20M $73.84M
YoY Change -22.69% 8.29% 51.07%
INVESTING ACTIVITIES
Capital Expenditures -$80.30M -$10.00M -$50.10M
YoY Change 60.28% 354.55% 247.92%
Acquisitions
YoY Change
Other Investing Activities $29.30M -$27.60M -$14.90M
YoY Change -296.64% -72.01% 186.54%
Cash From Investing Activities -$51.02M -$37.60M -$65.04M
YoY Change -21.56% -62.7% 232.07%
FINANCING ACTIVITIES
Cash Dividend Paid $46.82M $42.70M
YoY Change 9.64% 8.22%
Common Stock Issuance & Retirement, Net -$87.00K $35.91M
YoY Change -100.24% -64230.36%
Debt Paid & Issued, Net $304.0K $296.0K
YoY Change 2.7%
Cash From Financing Activities $58.08M -19.20M -$3.156M
YoY Change -1940.43% -137.5% -89.02%
NET CHANGE
Cash From Operating Activities $57.08M 56.20M $73.84M
Cash From Investing Activities -$51.02M -37.60M -$65.04M
Cash From Financing Activities $58.08M -19.20M -$3.156M
Net Change In Cash $64.15M -600.0K $5.642M
YoY Change 1036.99% -126.09% 952.61%
FREE CASH FLOW
Cash From Operating Activities $57.08M $56.20M $73.84M
Capital Expenditures -$80.30M -$10.00M -$50.10M
Free Cash Flow $137.4M $66.20M $123.9M
YoY Change 10.85% 22.37% 95.86%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000877860
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44650002 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44587486 shares
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44650002 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44587486 shares
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.1025
CY2019Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.05
CY2020Q1 nhi Litigation Settlement Payments Expected Term Years
LitigationSettlementPaymentsExpectedTermYears
P5Y0M0D
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q1 dei Entity File Number
EntityFileNumber
001-10822
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
National Health Investors Inc
CY2020Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2020Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
62-1470956
CY2020Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
222 Robert Rose Drive
CY2020Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Murfreesboro
CY2020Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TN
CY2020Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
37129
CY2020Q1 dei City Area Code
CityAreaCode
(615)
CY2020Q1 dei Local Phone Number
LocalPhoneNumber
890-9100
CY2020Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
CY2020Q1 dei Trading Symbol
TradingSymbol
NHI
CY2020Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
44650002 shares
CY2020Q1 us-gaap Land
Land
219575000 USD
CY2019Q4 us-gaap Land
Land
213617000 USD
CY2020Q1 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
2990554000 USD
CY2019Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
2836673000 USD
CY2020Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
18003000 USD
CY2019Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
24556000 USD
CY2020Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3228132000 USD
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3074846000 USD
CY2020Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
534905000 USD
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
514453000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2693227000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2560393000 USD
CY2020Q1 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
286320000 USD
CY2019Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
340143000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46049000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5215000 USD
CY2020Q1 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
85629000 USD
CY2019Q4 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
86044000 USD
CY2020Q1 us-gaap Real Estate Heldforsale
RealEstateHeldforsale
0 USD
CY2019Q4 us-gaap Real Estate Heldforsale
RealEstateHeldforsale
18420000 USD
CY2020Q1 us-gaap Other Assets
OtherAssets
56610000 USD
CY2020Q1 us-gaap Other Assets
OtherAssets
56610000 USD
CY2019Q4 us-gaap Other Assets
OtherAssets
32020000 USD
CY2020Q1 us-gaap Assets
Assets
3167835000 USD
CY2019Q4 us-gaap Assets
Assets
3042235000 USD
CY2020Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1548904000 USD
CY2019Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1440465000 USD
CY2020Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
34701000 USD
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
26313000 USD
CY2020Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
49226000 USD
CY2019Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
46817000 USD
CY2020Q1 us-gaap Security Deposit Liability
SecurityDepositLiability
10638000 USD
CY2019Q4 us-gaap Security Deposit Liability
SecurityDepositLiability
10638000 USD
CY2020Q1 us-gaap Deferred Revenue
DeferredRevenue
17373000 USD
CY2019Q4 us-gaap Deferred Revenue
DeferredRevenue
19750000 USD
CY2020Q1 us-gaap Liabilities
Liabilities
1660842000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
1543983000 USD
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
447000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
446000 USD
CY2020Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1505001000 USD
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1505948000 USD
CY2020Q1 us-gaap Cumulative Earnings Deficit
CumulativeEarningsDeficit
2241000 USD
CY2019Q4 us-gaap Cumulative Earnings Deficit
CumulativeEarningsDeficit
-5331000 USD
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-12131000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3432000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
1495558000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
1497631000 USD
CY2020Q1 us-gaap Minority Interest
MinorityInterest
11435000 USD
CY2019Q4 us-gaap Minority Interest
MinorityInterest
621000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1506993000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1498252000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3167835000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3042235000 USD
CY2020Q1 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
76527000 USD
CY2019Q1 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
70953000 USD
CY2020Q1 us-gaap Interest Income Operating
InterestIncomeOperating
6549000 USD
CY2019Q1 us-gaap Interest Income Operating
InterestIncomeOperating
5154000 USD
CY2020Q1 us-gaap Revenues
Revenues
83076000 USD
CY2019Q1 us-gaap Revenues
Revenues
76107000 USD
CY2020Q1 us-gaap Depreciation
Depreciation
20443000 USD
CY2019Q1 us-gaap Depreciation
Depreciation
18491000 USD
CY2020Q1 us-gaap Interest Expense
InterestExpense
14140000 USD
CY2019Q1 us-gaap Interest Expense
InterestExpense
13518000 USD
CY2020Q1 us-gaap Legal Fees
LegalFees
334000 USD
CY2019Q1 us-gaap Legal Fees
LegalFees
270000 USD
CY2020Q1 nhi Franchise Excise And Other Taxes
FranchiseExciseAndOtherTaxes
243000 USD
CY2019Q1 nhi Franchise Excise And Other Taxes
FranchiseExciseAndOtherTaxes
545000 USD
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4311000 USD
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4014000 USD
CY2020Q1 nhi Lessor Property Costs Paid From Tenant Escrow
LessorPropertyCostsPaidFromTenantEscrow
1553000 USD
CY2019Q1 nhi Lessor Property Costs Paid From Tenant Escrow
LessorPropertyCostsPaidFromTenantEscrow
1090000 USD
CY2020Q1 nhi Loanand Lease Lossesand Recoveries Net
LoanandLeaseLossesandRecoveriesNet
1555000 USD
CY2019Q1 nhi Loanand Lease Lossesand Recoveries Net
LoanandLeaseLossesandRecoveriesNet
2500000 USD
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
42579000 USD
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
40428000 USD
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-442000 USD
CY2019Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
CY2020Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
21007000 USD
CY2019Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
0 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
61062000 USD
CY2019Q1 us-gaap Profit Loss
ProfitLoss
35679000 USD
CY2020Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
39000 USD
CY2019Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
61023000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
35679000 USD
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44613593 shares
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42825824 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44618139 shares
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43125032 shares
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.37
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.83
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.37
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.83
CY2020Q1 us-gaap Profit Loss
ProfitLoss
61062000 USD
CY2019Q1 us-gaap Profit Loss
ProfitLoss
35679000 USD
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-9191000 USD
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-665000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
-492000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
292000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-8699000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-957000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
52363000 USD
CY2019Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
34722000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
39000 USD
CY2019Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
52324000 USD
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
34722000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
61062000 USD
CY2019Q1 us-gaap Profit Loss
ProfitLoss
35679000 USD
CY2020Q1 us-gaap Depreciation
Depreciation
20443000 USD
CY2019Q1 us-gaap Depreciation
Depreciation
18491000 USD
CY2020Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1173000 USD
CY2019Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1263000 USD
CY2020Q1 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-129000 USD
CY2019Q1 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-119000 USD
CY2020Q1 us-gaap Amortization Of Lease Incentives
AmortizationOfLeaseIncentives
236000 USD
CY2019Q1 us-gaap Amortization Of Lease Incentives
AmortizationOfLeaseIncentives
168000 USD
CY2020Q1 us-gaap Straight Line Rent
StraightLineRent
-5177000 USD
CY2019Q1 us-gaap Straight Line Rent
StraightLineRent
-5228000 USD
CY2020Q1 us-gaap Other Noncash Income
OtherNoncashIncome
888000 USD
CY2019Q1 us-gaap Other Noncash Income
OtherNoncashIncome
548000 USD
CY2020Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
21007000 USD
CY2019Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
0 USD
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-442000 USD
CY2019Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
CY2020Q1 nhi Loanand Lease Lossesand Recoveries Net
LoanandLeaseLossesandRecoveriesNet
1555000 USD
CY2019Q1 nhi Loanand Lease Lossesand Recoveries Net
LoanandLeaseLossesandRecoveriesNet
2500000 USD
CY2020Q1 nhi Paymentof Tenant Lease Incentives
PaymentofTenantLeaseIncentives
0 USD
CY2019Q1 nhi Paymentof Tenant Lease Incentives
PaymentofTenantLeaseIncentives
-1250000 USD
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1845000 USD
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2001000 USD
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-357000 USD
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2961000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1497000 USD
CY2019Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1597000 USD
CY2020Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-619000 USD
CY2019Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
16322000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
57082000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
73837000 USD
CY2020Q1 us-gaap Payments To Acquire Mortgage Notes Receivable
PaymentsToAcquireMortgageNotesReceivable
20298000 USD
CY2019Q1 us-gaap Payments To Acquire Mortgage Notes Receivable
PaymentsToAcquireMortgageNotesReceivable
11002000 USD
CY2020Q1 us-gaap Proceeds From Sale And Collection Of Mortgage Notes Receivable
ProceedsFromSaleAndCollectionOfMortgageNotesReceivable
14288000 USD
CY2019Q1 us-gaap Proceeds From Sale And Collection Of Mortgage Notes Receivable
ProceedsFromSaleAndCollectionOfMortgageNotesReceivable
300000 USD
CY2020Q1 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
80335000 USD
CY2019Q1 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
50122000 USD
CY2020Q1 nhi Payments To Renovate Real Estate
PaymentsToRenovateRealEstate
3057000 USD
CY2019Q1 nhi Payments To Renovate Real Estate
PaymentsToRenovateRealEstate
4215000 USD
CY2020Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
875000 USD
CY2019Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0 USD
CY2020Q1 us-gaap Proceeds From Sale Of Wholly Owned Real Estate And Real Estate Acquired In Settlement Of Loans
ProceedsFromSaleOfWhollyOwnedRealEstateAndRealEstateAcquiredInSettlementOfLoans
39260000 USD
CY2019Q1 us-gaap Proceeds From Sale Of Wholly Owned Real Estate And Real Estate Acquired In Settlement Of Loans
ProceedsFromSaleOfWhollyOwnedRealEstateAndRealEstateAcquiredInSettlementOfLoans
0 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-51017000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-65039000 USD
CY2020Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
125000000 USD
CY2019Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
95000000 USD
CY2020Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
17000000 USD
CY2019Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
90000000 USD
CY2020Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
304000 USD
CY2019Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
296000 USD
CY2020Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
CY2019Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
67000 USD
CY2020Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
16000 USD
CY2019Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
0 USD
CY2020Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
13000 USD
CY2019Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
0 USD
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2705000 USD
CY2019Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1006000 USD
CY2020Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2019Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
35913000 USD
CY2020Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
87000 USD
CY2019Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
CY2020Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
46817000 USD
CY2019Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
42700000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
58084000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3156000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
64149000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5642000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15669000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9912000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
79818000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15554000 USD
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
12462000 USD
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
11901000 USD
CY2020Q1 nhi Changein Straightline Rent Receivable Investmentsin Real Estate
ChangeinStraightlineRentReceivableInvestmentsinRealEstate
0 USD
CY2019Q1 nhi Changein Straightline Rent Receivable Investmentsin Real Estate
ChangeinStraightlineRentReceivableInvestmentsinRealEstate
38000000 USD
CY2020Q1 nhi Additions Through Settlement Of Mortgage Note
AdditionsThroughSettlementOfMortgageNote
59350000 USD
CY2019Q1 nhi Additions Through Settlement Of Mortgage Note
AdditionsThroughSettlementOfMortgageNote
0 USD
CY2020Q1 nhi Increase In Mortgage Note Receivable From Sale Of Real Estate
IncreaseInMortgageNoteReceivableFromSaleOfRealEstate
4000000 USD
CY2019Q1 nhi Increase In Mortgage Note Receivable From Sale Of Real Estate
IncreaseInMortgageNoteReceivableFromSaleOfRealEstate
0 USD
CY2020Q1 nhi Changein Other Assets Investmentsin Real Estate
ChangeinOtherAssetsInvestmentsinRealEstate
0 USD
CY2019Q1 nhi Changein Other Assets Investmentsin Real Estate
ChangeinOtherAssetsInvestmentsinRealEstate
176000 USD
CY2020Q1 nhi Changein Accounts Payable Investmentsin Real Estate Construction
ChangeinAccountsPayableInvestmentsinRealEstateConstruction
-234000 USD
CY2019Q1 nhi Changein Accounts Payable Investmentsin Real Estate Construction
ChangeinAccountsPayableInvestmentsinRealEstateConstruction
-1048000 USD
CY2020Q1 nhi Changein Accounts Payable Investmentsin Real Estate Acquisition
ChangeinAccountsPayableInvestmentsinRealEstateAcquisition
0 USD
CY2019Q1 nhi Changein Accounts Payable Investmentsin Real Estate Acquisition
ChangeinAccountsPayableInvestmentsinRealEstateAcquisition
1178000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1498252000 USD
CY2020Q1 us-gaap New Accounting Pronouncement Or Change In Accounting Principle Cumulative Effect Of Change On Equity Or Net Assets1
NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1
-4225000 USD
CY2020Q1 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
10791000 USD
CY2020Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
16000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
52363000 USD
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
85000 USD
CY2020Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2705000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1845000 USD
CY2020Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
49226000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1506993000 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1389713000 USD
CY2019Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
34722000 USD
CY2019Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
35913000 USD
CY2019Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1006000 USD
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2001000 USD
CY2019Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
45359000 USD
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1415984000 USD
CY2020Q1 nhi Variable Interest Entity Number Of Entities Not Primary Beneficiary
VariableInterestEntityNumberOfEntitiesNotPrimaryBeneficiary
7 properties
CY2020Q1 us-gaap Cash
Cash
46049000 USD
CY2019Q1 us-gaap Cash
Cash
5177000 USD
CY2020Q1 us-gaap Restricted Cash
RestrictedCash
33769000 USD
CY2019Q1 us-gaap Restricted Cash
RestrictedCash
10377000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
79818000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15554000 USD
CY2020Q1 us-gaap Lessor Operating Lease Renewal Term
LessorOperatingLeaseRenewalTerm
P5Y
CY2020Q1 us-gaap Use Of Estimates
UseOfEstimates
<span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Use of Estimates -</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span>
CY2020Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Reclassifications</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> - We have reclassified certain balances where necessary to conform the presentation of prior periods to the current period. These reclassifications had no effect on previously reported net income.</span>
CY2020Q1 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
225 properties
CY2020Q1 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
34
CY2020Q1 nhi Nonportfolio Assets Original Cost
NonportfolioAssetsOriginalCost
2532000 USD
CY2020Q1 nhi Real Estate Investment Property Portfolio Assets
RealEstateInvestmentPropertyPortfolioAssets
3225600000 USD
CY2020Q1 nhi Number Of Lessees
NumberOfLessees
33
CY2020Q1 nhi Real Estate Investments During The Period
RealEstateInvestmentsDuringThePeriod
149992000 USD
CY2020Q1 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
277788000 USD
CY2020Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
277910000 USD
CY2020Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
283430000 USD
CY2020Q1 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
275699000 USD
CY2020Q1 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
268238000 USD
CY2020Q1 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
1542215000 USD
CY2020Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
2925280000 USD
CY2020Q1 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
76527000 USD
CY2019Q1 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
70953000 USD
CY2020Q1 nhi Notes Receivable Excluded From Credit Loss Disclosures Credit Quality Indicator Metric Not Available
NotesReceivableExcludedFromCreditLossDisclosuresCreditQualityIndicatorMetricNotAvailable
4019000 USD
CY2020Q1 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
192837 USD
CY2020Q1 nhi Construction Note Receivable Balance Excluded
ConstructionNoteReceivableBalanceExcluded
94964000 USD
CY2020Q1 nhi Probability Of Default Increase Current Conditions Adjustment
ProbabilityOfDefaultIncreaseCurrentConditionsAdjustment
20
CY2020Q1 nhi Loss Given Default Increase Current Conditions Adjustment
LossGivenDefaultIncreaseCurrentConditionsAdjustment
20
CY2020Q1 nhi Estimated Credit Losses Current Conditions Adjustment Combined
EstimatedCreditLossesCurrentConditionsAdjustmentCombined
44
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
1600000 USD
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
5500000 USD
CY2020Q1 nhi Number Of Health Care Properties Related To Mortgage Notes Receivables
NumberOfHealthCarePropertiesRelatedToMortgageNotesReceivables
15 properties
CY2020Q1 us-gaap Guarantee Obligations Maximum Exposure
GuaranteeObligationsMaximumExposure
20063000 USD
CY2020Q1 us-gaap Guarantee Obligations Maximum Exposure
GuaranteeObligationsMaximumExposure
18974000 USD
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-442000 USD
CY2020Q1 nhi Accounts Receivableand Other Assets
AccountsReceivableandOtherAssets
3635000 USD
CY2019Q4 nhi Accounts Receivableand Other Assets
AccountsReceivableandOtherAssets
3212000 USD
CY2020Q1 us-gaap Incentive To Lessee
IncentiveToLessee
10565000 USD
CY2019Q4 us-gaap Incentive To Lessee
IncentiveToLessee
10146000 USD
CY2020Q1 us-gaap Escrow Deposit
EscrowDeposit
8208000 USD
CY2019Q4 us-gaap Escrow Deposit
EscrowDeposit
8208000 USD
CY2020Q1 us-gaap Restricted Cash
RestrictedCash
33769000 USD
CY2019Q4 us-gaap Restricted Cash
RestrictedCash
10454000 USD
CY2020Q1 us-gaap Equity Method Investments
EquityMethodInvestments
433000 USD
CY2019Q4 us-gaap Equity Method Investments
EquityMethodInvestments
0 USD
CY2020Q1 us-gaap Other Assets
OtherAssets
56610000 USD
CY2019Q4 us-gaap Other Assets
OtherAssets
32020000 USD
CY2020Q1 us-gaap Line Of Credit
LineOfCredit
408000000 USD
CY2019Q4 us-gaap Line Of Credit
LineOfCredit
300000000 USD
CY2020Q1 us-gaap Convertible Debt
ConvertibleDebt
59797000 USD
CY2019Q4 us-gaap Convertible Debt
ConvertibleDebt
59697000 USD
CY2020Q1 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
6453000 USD
CY2019Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
7076000 USD
CY2020Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1548904000 USD
CY2019Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1440465000 USD
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths
1244000 USD
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo
61291000 USD
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
784340000 USD
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour
351389000 USD
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive
154529000 USD
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive
203985000 USD
CY2020Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1556778000 USD
CY2020Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
1421000 USD
CY2020Q1 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
6453000 USD
CY2020Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1548904000 USD
CY2020Q1 nhi Credit Facility Current Revolving Borrowing Capacity
CreditFacilityCurrentRevolvingBorrowingCapacity
550000000 USD
CY2020Q1 nhi Credit Facility Current Revolving Borrowing Capacity
CreditFacilityCurrentRevolvingBorrowingCapacity
550000000 USD
CY2020Q1 us-gaap Line Of Credit Facility Unused Capacity Commitment Fee Percentage
LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
20
CY2020Q1 nhi Debt Instrument Variable Rate Basis Minimum
DebtInstrumentVariableRateBasisMinimum
99
CY2019Q4 nhi Debt Instrument Variable Rate Basis Minimum
DebtInstrumentVariableRateBasisMinimum
176
CY2019Q1 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
13074000 USD
CY2020Q1 us-gaap Derivative Instruments Loss Reclassified From Accumulated Oci Into Income Effective Portion
DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
492000 USD
CY2020Q1 us-gaap Unsecured Debt
UnsecuredDebt
400000000 USD
CY2020Q1 nhi Debt Leverage Limit Coupon Change Trigger
DebtLeverageLimitCouponChangeTrigger
0.50
CY2020Q1 us-gaap Debt Instrument Convertible Conversion Ratio1
DebtInstrumentConvertibleConversionRatio1
14.71
CY2020Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
67.97
CY2020Q1 us-gaap Debt Instrument Convertible Number Of Equity Instruments
DebtInstrumentConvertibleNumberOfEquityInstruments
882792 shares
CY2020Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
67.97
CY2020Q1 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
610000000 USD
CY2020Q1 us-gaap Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net
InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
7060000 USD
CY2019Q4 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
-3433000 USD
CY2020Q1 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
13003000 USD
CY2019Q1 us-gaap Derivative Instruments Loss Reclassified From Accumulated Oci Into Income Effective Portion
DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
292000 USD
CY2020Q1 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
98000 USD
CY2019Q1 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
157000 USD
CY2020Q1 nhi Amortization Of Financing Costs Exclusive Of Amounts Written Off
AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff
743000 USD
CY2019Q1 nhi Amortization Of Financing Costs Exclusive Of Amounts Written Off
AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff
893000 USD
CY2020Q1 us-gaap Interest Expense
InterestExpense
14140000 USD
CY2019Q1 us-gaap Interest Expense
InterestExpense
13518000 USD
CY2020Q1 us-gaap Loans And Leases Receivable Commitments Fixed Rates
LoansAndLeasesReceivableCommitmentsFixedRates
237250000 USD
CY2020Q1 nhi Notes Receivable Funding Commitment
NotesReceivableFundingCommitment
58458000 USD
CY2020Q1 us-gaap Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal
OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal
-25000 USD
CY2020Q1 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
300000 USD
CY2020Q1 nhi Maximum Commitment For All Active Development Projects
MaximumCommitmentForAllActiveDevelopmentProjects
46645000 USD
CY2020Q1 us-gaap Development In Process
DevelopmentInProcess
36450000 USD
CY2020Q1 nhi Remaining Unfunded Development Commitment
RemainingUnfundedDevelopmentCommitment
10195000 USD
CY2020Q1 us-gaap Litigation Settlement Amount Awarded From Other Party
LitigationSettlementAmountAwardedFromOtherParty
2850000 USD
CY2020Q1 us-gaap Proceeds From Legal Settlements
ProceedsFromLegalSettlements
60000 USD
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1845000 USD
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2001000 USD
CY2020Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
2124000 USD
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.54
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.17
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.051
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.055
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.168
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.186
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y10M24D
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y10M24D
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0131
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0250
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1004014 shares
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
920346 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1068005 shares
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1169516 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
600327 shares
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
678997 shares
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
61023000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
35679000 USD
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44613593 shares
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42825824 shares
CY2020Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
44613593 shares
CY2019Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
42825824 shares
CY2020Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4546 shares
CY2019Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
75695 shares
CY2020Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2019Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
223513 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44618139 shares
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43125032 shares
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.37
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.83
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.37
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.83
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
305862 shares
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17415 shares
CY2020Q1 nhi Common Stock Dividends Per Share Declared Regular
CommonStockDividendsPerShareDeclaredRegular
1.1025
CY2019Q1 nhi Common Stock Dividends Per Share Declared Regular
CommonStockDividendsPerShareDeclaredRegular
1.05

Files In Submission

Name View Source Status
0000877860-20-000069-index-headers.html Edgar Link pending
0000877860-20-000069-index.html Edgar Link pending
0000877860-20-000069.txt Edgar Link pending
0000877860-20-000069-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nhi-20200331.htm Edgar Link pending
nhi-20200331.xsd Edgar Link pending
nhi-20200331_cal.xml Edgar Link unprocessable
nhi-20200331_def.xml Edgar Link unprocessable
nhi-20200331_htm.xml Edgar Link completed
nhi-20200331_lab.xml Edgar Link unprocessable
nhi-20200331_pre.xml Edgar Link unprocessable
nhi-3312020x10qex311.htm Edgar Link pending
nhi-3312020x10qex312.htm Edgar Link pending
nhi-3312020x10qex32.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending